| Literature DB >> 33295462 |
Marcus Vinicius Simões1, Silvia Marinho Martins Alves2, Fabio Fernandes3, Otávio Rizzi Coelho Filho4, Sandrigo Mangini3.
Abstract
Recent evidence suggests cardiac amyloidosis (CA) is a mostly underdiagnosed condition, particularly in the transthyretin-mediated form, and is a frequent cause of heart failure with preserved ejection fraction (HFpEF) in the elderly. New paradigms about CA also involve the development of disease-modifying specific therapies. This article summarizes these new concepts.Entities:
Mesh：
Substances：
Year: 2020 PMID： 33295462 DOI： 10.36660/abc.20201126
Source DB: PubMed Journal: Arq Bras Cardiol ISSN： 0066-782X Impact factor: 2.000